Built for Bold: CNS Medical Writing Expert InsightsInside CRC

Built for Bold: CNS Medical Writing

The issues that can complicate a CNS clinical trial often do not surface where teams…

Hayley BellOctober 14, 2026

World Mental Health Day 2026: Real Voices, Real Change Inside CRC

World Mental Health Day 2026: Real Voices, Real Change

Each year on October 10, World Mental Health Day brings attention to the importance of…

Hayley BellOctober 13, 2026

Connect With CRC at CTAD 2026 Conferences & Events

Connect With CRC at CTAD 2026

CRC will attend the Clinical Trials on Alzheimer’s Disease Conference (CTAD), November 16-19, 2026 in…

Hayley BellOctober 6, 2026

Join CRC at CNS Summit 2026 Conferences & Events

Join CRC at CNS Summit 2026

CRC will attend CNS Summit 2026, November 1-4 at Encore Boston Harbor. The event brings…

Hayley BellOctober 6, 2026

Seaport Therapeutics Reports Positive Phase 1 GlyphAllo Results Using CRC MiniSim Breaking News

Seaport Therapeutics Reports Positive Phase 1 GlyphAllo Results Using CRC MiniSim

On September 9, Seaport Therapeutics announced positive topline results from its Phase 1 Driving Simulation…

Hayley BellOctober 1, 2026

Connect with CRC at SCRS 2026 Conferences & Events

Connect with CRC at SCRS 2026

SCRS 2026 The SCRS Global Site Solutions Summit brings together sites, sponsors, CROs, and solution…

cogres1September 17, 2026

FDA Finalizes Psychedelic Drug Guidance: What Sponsors Need to Know Expert Insights

FDA Finalizes Psychedelic Drug Guidance: What Sponsors Need to Know

In July 2026, the U.S. Food and Drug Administration (FDA) issued its final guidance, Psychedelic…

Hayley BellAugust 19, 2026

Hybrid and Decentralized CNS Clinical Trials: Finding the Right Balance Expert Insights

Hybrid and Decentralized CNS Clinical Trials: Finding the Right Balance

Key Takeaways: Both decentralized clinical trial (DCT) and hybrid models can be viable in CNS…

Hayley BellAugust 18, 2026

Built for Bold: CNS Clinical Trial Management Expert InsightsInside CRC

Built for Bold: CNS Clinical Trial Management

One of the first lessons CNS clinical trial management teaches you is that what works…

Hayley BellJuly 13, 2026

Tom Zoda, Ph.D., Chairs ASCP 2026 Panel on Preventable Failure Risk in CNS Clinical Trials Breaking News

Tom Zoda, Ph.D., Chairs ASCP 2026 Panel on Preventable Failure Risk in CNS Clinical Trials

ST. PETERSBURG, Fla., June 3, 2026 /PRNewswire/ -- Cognitive Research Corporation (CRC) Chief Executive Officer…

cogres1June 3, 2026

Why Driving Impairment Evaluation Is Becoming More Important in CNS Drug Development Expert Insights

Why Driving Impairment Evaluation Is Becoming More Important in CNS Drug Development

Key takeaways from the 2026 Lifesavers Conference on FDA driving guidance and functional safety assessment…

cogres1May 26, 2026

Research Rising: Clinical Trials Day 2026 Inside CRC

Research Rising: Clinical Trials Day 2026

Clinical Trials Day recognizes the people who make clinical research possible. In CNS drug development,…

cogres1May 20, 2026